Use of Etanercept in Amyloidosis Secondary to Rheumatoid Arthritis: A Report of Two Cases

Rheumatoid arthritis (RA) is one of the most common causes of AA amyloidosis. Most patients are asymptomatic and only when there are large deposits in certain organs, functional problems arise. We report two patients with amyloidosis secondary to RA, with renal and intestinal involvement, who respon...

Full description

Saved in:
Bibliographic Details
Published in:Reumatología clinica (Barcelona) 2011-11, Vol.7 (6), p.397-400
Main Authors: Macías Fernández, Inmaculada, Fernández Rodríguez, Antonia María, García Pérez, Sergio
Format: Article
Language:English
Subjects:
Amiloidosis
Amyloidosis
Artritis reumatoide
Etanercept
Rheumatoid arthritis
Citations: Items that this one cites
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Rheumatoid arthritis (RA) is one of the most common causes of AA amyloidosis. Most patients are asymptomatic and only when there are large deposits in certain organs, functional problems arise. We report two patients with amyloidosis secondary to RA, with renal and intestinal involvement, who responded to treatment with etanercept. La artritis reumatoide (AR) es una de las causas más frecuentes de amiloidosis tipo AA. En la mayoría de los pacientes es asintomática y sólo cuando existen grandes depósitos en determinados órganos ocasiona problemas funcionales. Presentamos 2 pacientes con amiloidosis secundaria a AR, con afectación renal e intestinal, que respondieron al tratamiento con etanercept.
ISSN:2173-5743
2173-5743
DOI:10.1016/j.reumae.2011.09.001